logo

Passage Bio, Inc. (PASG)



Trade PASG now with
  Date
  Headline
7/6/2022 7:31:25 AM Passage Bio Appoints Michael Kamarck To Board
6/8/2022 8:10:47 AM Passage Bio: FDA Clears IND Application For PBML04 For Metachromatic Leukodystrophy; Stock Up
3/15/2022 7:29:08 AM Passage Bio Provides Update On Strategic Priorities; To Reduce Workforce By About 13%
12/17/2021 7:14:56 AM Passage Bio: IDMC Recommended Proceeding To Additional Planned Cohorts In Imagine-1 Clinical Study
9/7/2021 7:15:26 AM Passage Bio Names Maxine Gowen Chairwoman Of Board Of Directors
7/19/2021 7:10:33 AM Passage Bio Names Maria Törnsén Chief Commercial Officer
6/1/2021 7:13:13 AM Passage Bio Adds Derrell Porter To Its Board
4/5/2021 7:04:22 AM Passage Bio Says European Commission Has Granted Orphan Designation For PBKR03
4/1/2021 7:16:26 AM Passage Bio Says First Patient Dosed In Global Phase 1/2 Clinical Trial Program For PBGM01
3/22/2021 7:21:36 AM Passage Bio Appoints Eliseo Salinas As Chief Research & Development Officer
3/8/2021 7:15:39 AM Passage Bio Says FDA Grants Fast Track Designation To Three Gene Therapy Candidates Targeting Rare CNS Disorders
1/21/2021 9:04:33 PM Passage Bio Prices Public Offering Of 7 Mln Shares Of Common Stock At $22.00/shr